Orthopedics Medical News about raloxifene

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Rapid correction of low vitamin D status in nursing home residents

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. Medicare pay-for-reporting effort draws fire from frustrated doctors

5. Debunking Myths in the US Healthcare System

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

The effects of long-term raloxifene and estradiol treatments on bone in a patient with congenital aromatase deficiency
Bone , 08/06/09

Zirilli L et al. – This study shows that the management of aromatase deficiency in the male cannot consider raloxifene as a first choice treatment, but should be still based on estrogen replacement treatment since in this patient the completion of bone maturation has only been obtained once estradiol substitution was performed. The present case also demonstrates that raloxifene is able to improve BMD in aromatase–deficient men.

<< Previous
Anabolics and Cardiomyopathy in a Bodybuilder

Next >>
Computed Tomographic Angiography in Proximal Femoral Focal...